Results 81 to 90 of about 113,181 (243)

Epidemiological Characteristics of Chronic Viral Hepatitis in Kazakhstan: Data from Unified Nationwide Electronic Healthcare System 2014–2019

open access: yesInfection and Drug Resistance, 2022
Aiymkul Ashimkhanova,1,* Dmitriy Syssoyev,1,* Arnur Gusmanov,1 Kakharman Yesmembetov,2 Arina Yespotayeva,3 Anara Abbay,1 Aiymzhan Nurpeissova,4 Antonio Sarria-Santamera,1 Abduzhappar Gaipov1 1Department of Medicine, Nazarbayev University School ...
Ashimkhanova A   +8 more
doaj  

Antiviral regulator TRIM25 as a prognostic marker of better survival in Merkel cell carcinoma: Association with MCPyV status

open access: yesInternational Journal of Cancer, EarlyView.
What's New? TRIM25 is known for its role in antiviral immunity and association with poor prognosis in various cancers. This study reveals an association between high TRIM25 expression and Merkel cell polyomavirus positivity in Merkel cell carcinoma.
Klaus W. Fagerstedt   +6 more
wiley   +1 more source

NEEDLE CHANGING AND OCCURRENCE OF LOCAL ADVERSE EFFECTS AFTER HB VACCINATION

open access: yesنشریه پرستاری ایران, 2004
Health professionals for adminstering intramascular (IM) injections use two usual techniques. First of all the injectable is drawn up, using a needle which is then changed with a new one before administration.
M. Payami Boosari, N. Mosavinasab
doaj  

Hepatitis B and C Virus Infections among Blood Donors in Blood Transfusion Center, Pokhara, Nepal: Seroprevalence and its Associated Risk Factors

open access: yesNepal Journal of Biotechnology, 2018
Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) infections lead to chronic diseases and are the most common causes of liver cirrhosis and cancer in developing countries like Nepal.
Gyanendra Bikram Shah   +4 more
doaj   +1 more source

Single versus repeated intravenous oncolytic reovirus infusions: Implications for immune modulation and rationalised scheduling of therapy in hepatocellular carcinoma

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Oncolytic viruses are a promising immunotherapeutic approach against many malignancies. However, it is unclear whether repeated doses have improved therapeutic value or may trigger greater side effects, especially in patients with hepatocellular carcinoma whose liver is chronically damaged.
Karen J. Scott   +10 more
wiley   +1 more source

Hepatitis B Vaccine Response in Children of Vaccinated Versus Unvaccinated Mothers: A Retrospective Cohort Study. [PDF]

open access: yesJ Viral Hepat
ABSTRACT Universal infant hepatitis B (HBV) vaccination is highly effective in preventing infection. However, little is known about whether a mother's HBV vaccination history influences her child's immune response to routine immunisation. We aimed to compare vaccine‐induced antibody responses in children of vaccinated and unvaccinated mothers.
Shibli S   +4 more
europepmc   +2 more sources

Retrospective Analysis of Blood Donor Deferral Reasons and Optimization Suggestions for Deferral Policies

open access: yesiLABMED, EarlyView.
This retrospective study analyzes the deferral reasons for 148,282 blood donors during 2019–2023 (overall deferral rate: 12.37%), identifying primary deferral reasons (e.g., elevated ALT for temporary deferral at 51.33%, HBsAg positivity for permanent deferral at 4.12%).
Limei Feng   +5 more
wiley   +1 more source

Hepatitis and HIV Co-infection at University of Gondar Specialized Referral Hospital: Northwest Ethiopia

open access: yesHepatic Medicine: Evidence and Research, 2021
Meseret Ayelign,1 Melak Aynalem,2 Nega Berhane3 1Department of Molecular Biology, Specialized Referral Hospital, University of Gondar, Gondar, Ethiopia; 2Department of Hematology and Immunohematology, School of Biomedical and Laboratory Sciences, College
Ayelign M, Aynalem M, Berhane N
doaj  

Curcuminoids amplify host innate antiviral immunity via the CRYAB‐RBM26 axis in viral infection

open access: yesiMeta, EarlyView.
DMC/CUR antagonize viral hijacking of host nucleic acid resources and finely regulate the induction and effector phases of the type I interferon (IFN‐I) pathway through the CRYAB‐RBM26 axis. This molecular axis serves as a key downstream regulator for DMC/CUR activation of the IFN‐I pathway.
Tingting Chen   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy